Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 51655-818

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 51655-818). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51655-818-26 (51655 818 26 Rev A 01 23)

Label for Cyclobenzaprine Hydrochloride Tablets USP, 5 mg, film-coated tablets. The package contains 90 tablets and is labeled for prescription use only. The label indicates storage instructions between 20° - 25°C (68° - 77°F). The product is repackaged by Northwind Pharmaceuticals, Indianapolis, IN. It includes lot, serial, and expiration identifiers along with a barcode and QR code.*

FDA Label Image

Image (Cyclobenzaprine HCl Tabs Structure)

Chemical structure of cyclobenzaprine hydrochloride, showing the molecular arrangement with labeled chemical groups including hydrocarbon and nitrogen atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.